JPMC MMCAP MMS2401037 Padagis Naloxone Participation

The State of Illinois Chief Procurement Office for General Services (CPO-GS) has initiated a procurement opportunity through the Midwest Multistate Contracting Alliance for Pharmacy (MMCAP) for Naloxone Hydrochloride 4mg Nasal Spray, specifically targeting St. Clair County. The contract, identified by MMCAP number MMS2401037, was awarded to Padagis US LLC through a Request for Proposal process, focusing on securing an indefinite quantity of naloxone nasal spray for governmental units and qualified not-for-profit organizations. The procurement aims to provide critical overdose prevention medication through a comprehensive contract mechanism. The contract's initial term is set for 32 months, with the due date for participation or response established as October 29, 2025. The procurement was evaluated based on factors deemed most advantageous to the State, with the primary objective of ensuring widespread access to emergency overdose intervention medication. The agency contact for this procurement is Joshua Sergent, located in Springfield, Illinois, who can be reached at 217-685-9312 or joshua.sergent@illinois.gov for any additional inquiries.

The contract appears to be broadly accessible to governmental units and qualified not-for-profit organizations, with no specific set-aside designations for disadvantaged enterprises noted in the documentation. No Business Enterprise Program (BEP) or Veterans Business Program (VBP) utilization goals were specified, with both categories reporting 0% participation. The total estimated award amount for this contract is $42,000,000, indicating a significant investment in naloxone nasal spray procurement. The contract structure allows for potential renewal terms, providing flexibility for participating organizations. Padagis US LLC has been selected as the sole vendor for this contract, with no mention of alternative or incumbent vendors. The procurement does not appear to have specific technological integration requirements, focusing instead on the direct procurement of medical supplies. The broad eligibility and substantial award value suggest a strategic approach to addressing public health needs through a centralized procurement mechanism.